115 related articles for article (PubMed ID: 19774597)
1. Adsorption of the Pt(II) anticancer drug carboplatin by mesoporous silica.
Di Pasqua AJ; Wallner S; Kerwood DJ; Dabrowiak JC
Chem Biodivers; 2009 Sep; 6(9):1343-9. PubMed ID: 19774597
[TBL] [Abstract][Full Text] [Related]
2. Activation of carboplatin by carbonate.
Di Pasqua AJ; Goodisman J; Kerwood DJ; Toms BB; Dubowy RL; Dabrowiak JC
Chem Res Toxicol; 2006 Jan; 19(1):139-49. PubMed ID: 16411667
[TBL] [Abstract][Full Text] [Related]
3. Role of carbonate in the cytotoxicity of carboplatin.
Di Pasqua AJ; Goodisman J; Kerwood DJ; Toms BB; Dubowy RL; Dabrowiak JC
Chem Res Toxicol; 2007 Jun; 20(6):896-904. PubMed ID: 17497898
[TBL] [Abstract][Full Text] [Related]
4. Modification of carboplatin by Jurkat cells.
Di Pasqua AJ; Goodisman J; Kerwood DJ; Toms BB; Dabrowiak JC
J Inorg Biochem; 2007 Oct; 101(10):1438-41. PubMed ID: 17655933
[TBL] [Abstract][Full Text] [Related]
5. Isomer-dependent adsorption and release of cis- and trans-platin anticancer drugs by mesoporous silica nanoparticles.
Tao Z; Xie Y; Goodisman J; Asefa T
Langmuir; 2010 Jun; 26(11):8914-24. PubMed ID: 20148511
[TBL] [Abstract][Full Text] [Related]
6. Comparison of different theory models and basis sets in the calculations of structures and 13C NMR spectra of [Pt(en)(CBDCA-O, O')], an analogue of the antitumor drug carboplatin.
Gao H; Wei X; Liu X; Yan T
J Phys Chem B; 2010 Mar; 114(11):4056-62. PubMed ID: 20199040
[TBL] [Abstract][Full Text] [Related]
7. NMR study of the adsorption-desorption kinetics of dissolved tetraalanine in MCM-41 mesoporous material.
Pizzanelli S; Kababya S; Frydman V; Landau M; Vega S
J Phys Chem B; 2005 Apr; 109(16):8029-39. PubMed ID: 16851938
[TBL] [Abstract][Full Text] [Related]
8. Kinetic study on the reactions of platinum drugs with glutathione.
Hagrman D; Goodisman J; Souid AK
J Pharmacol Exp Ther; 2004 Feb; 308(2):658-66. PubMed ID: 14610218
[TBL] [Abstract][Full Text] [Related]
9. 2-Mercaptothiazoline modified mesoporous silica for mercury removal from aqueous media.
Pérez-Quintanilla D; del Hierro I; Fajardo M; Sierra I
J Hazard Mater; 2006 Jun; 134(1-3):245-56. PubMed ID: 16326000
[TBL] [Abstract][Full Text] [Related]
10. Mesoporous silica microparticles enhance the cytotoxicity of anticancer platinum drugs.
Tao Z; Toms B; Goodisman J; Asefa T
ACS Nano; 2010 Feb; 4(2):789-94. PubMed ID: 20131868
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and anticancer activity of [2-hydroxy-1,3-diaminopropane-kappa 2N,N'] platinum(II) complexes.
Liu W; Chen X; Xie M; Lou L; Ye Q; Yu Y; Hou S
J Inorg Biochem; 2008 Oct; 102(10):1942-6. PubMed ID: 18707762
[TBL] [Abstract][Full Text] [Related]
12. Monitoring local disposition kinetics of carboplatin in vivo after subcutaneous injection in rats by means of 195Pt NMR.
Becker M; Port RE; Zabel HJ; Zeller WJ; Bachert P
J Magn Reson; 1998 Jul; 133(1):115-22. PubMed ID: 9654475
[TBL] [Abstract][Full Text] [Related]
13. Effective controlled release of captopril by silylation of mesoporous MCM-41.
Qu F; Zhu G; Huang S; Li S; Qiu S
Chemphyschem; 2006 Feb; 7(2):400-6. PubMed ID: 16411260
[TBL] [Abstract][Full Text] [Related]
14. Physico-chemical characterization of MCM-41 silica spheres made by the pseudomorphic route and grafted with octadecyl chains.
Kailasam K; Müller K
J Chromatogr A; 2008 May; 1191(1-2):125-35. PubMed ID: 18308328
[TBL] [Abstract][Full Text] [Related]
15. Mesoporous silica material TUD-1 as a drug delivery system.
Heikkilä T; Salonen J; Tuura J; Hamdy MS; Mul G; Kumar N; Salmi T; Murzin DY; Laitinen L; Kaukonen AM; Hirvonen J; Lehto VP
Int J Pharm; 2007 Feb; 331(1):133-8. PubMed ID: 17046183
[TBL] [Abstract][Full Text] [Related]
16. pH-responsive controlled release of antitumour-active polyoxometalate from mesoporous silica materials.
Sun G; Chang Y; Li S; Li Q; Xu R; Gu J; Wang E
Dalton Trans; 2009 Jun; (23):4481-7. PubMed ID: 19488446
[TBL] [Abstract][Full Text] [Related]
17. Formation of carbonato and hydroxo complexes in the reaction of platinum anticancer drugs with carbonate.
Di Pasqua AJ; Centerwall CR; Kerwood DJ; Dabrowiak JC
Inorg Chem; 2009 Feb; 48(3):1192-7. PubMed ID: 19113934
[TBL] [Abstract][Full Text] [Related]
18. Hydrogen bonding of water confined in mesoporous silica MCM-41 and SBA-15 studied by 1H solid-state NMR.
Grünberg B; Emmler T; Gedat E; Shenderovich I; Findenegg GH; Limbach HH; Buntkowsky G
Chemistry; 2004 Nov; 10(22):5689-96. PubMed ID: 15470692
[TBL] [Abstract][Full Text] [Related]
19. Improvement of dissolution rate of piroxicam by inclusion into MCM-41 mesoporous silicate.
Ambrogi V; Perioli L; Marmottini F; Giovagnoli S; Esposito M; Rossi C
Eur J Pharm Sci; 2007 Nov; 32(3):216-22. PubMed ID: 17826966
[TBL] [Abstract][Full Text] [Related]
20. Preparation, characterization, and Zn(2+) adsorption behavior of chemically modified MCM-41 with 5-mercapto-1-methyltetrazole.
Pérez-Quintanilla D; Sánchez A; del Hierro I; Fajardo M; Sierra I
J Colloid Interface Sci; 2007 Sep; 313(2):551-62. PubMed ID: 17532331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]